RE:RE:RE:Doing some dd
Their IPO price was $6, now is trading close to 3 times higher than IPO price. All the beautiful things you mentioned have already factored into the price.
The liquidity of TRUL is not very impressive, which could give huge swings to the price fluctuation. Tmr hopefully the result will go well as you expected. Otherwise prepare for a free fall.
CURA started much lower with 40% discount to the IPO price at the moment. Initial revenue debut was low, but leave a lot of room to increase in terms of share price upside potential.
The right thing to do as you see in the cannabis sector is to sell on the news buy on the rumors. Now is time to sell TRUL and put your capital in CURA.
People already made 3 times in TRUL which is good, now should think about tripling your money in CURA.